MACS®/CliniMACS® Platform Development
Enabling Technology for Cell & Gene Therapies
CommercialActive
Key Facts
Indication
Enabling Technology for Cell & Gene Therapies
Phase
Commercial
Status
Active
Company
About Miltenyi Biotec
Miltenyi Biotec, founded in 1989 and headquartered in Bergisch Gladbach, Germany, is a privately-held global leader in providing enabling technologies for the life sciences, particularly in the rapidly growing fields of cell and gene therapy. The company operates on a platform and services business model, generating revenue from the sale of its proprietary instruments, reagents, and contract development and manufacturing services. Its integrated solutions, built around technologies like MACS® and CliniMACS®, are industry standards for cell separation and processing, positioning it as a critical infrastructure provider for both research and clinical applications.
View full company profile